BR9905867A - Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula - Google Patents
Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célulaInfo
- Publication number
- BR9905867A BR9905867A BR9905867-7A BR9905867A BR9905867A BR 9905867 A BR9905867 A BR 9905867A BR 9905867 A BR9905867 A BR 9905867A BR 9905867 A BR9905867 A BR 9905867A
- Authority
- BR
- Brazil
- Prior art keywords
- human erythropoietin
- recombinant human
- gene
- epo
- cell
- Prior art date
Links
- 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 title abstract 3
- 101000920686 Homo sapiens Erythropoietin Proteins 0.000 title abstract 3
- 102000044890 human EPO Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000003951 Erythropoietin Human genes 0.000 abstract 2
- 108090000394 Erythropoietin Proteins 0.000 abstract 2
- 229940105423 erythropoietin Drugs 0.000 abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- 101150002621 EPO gene Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000008488 polyadenylation Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
<B>LINHAGEM CELULAR PRODUTORA DE ERITROPOETINA HUMANA RECOMBINANTE E A ERITROPOETINA HUMANA RECOMBINANTE PRODUZIDA POR ESTA CéLULA<D>. O gen codificante para eritropoetina humana (EPO) foi obtido a partir de DNA genómico humana. O gen utilizado não inclui fragmentos de regiões flanqueantes 5' e 3' do gen de EPO que não codificam para a proteína. O gen foi clonado em um plasmídeo de expressão para células eucarióticas que tem como únicos elementos de controle da expressão o promotor primário de vírus SV40 e seu sinal de poliadenilação. As células recombinantes resultantes da transfecção com as construções genéticas utilizadas produz inesperadamente mais de 50 mg de EPO recombinante por litro de meio de cultivo por dia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP980105609 AR008358A1 (es) | 1998-11-06 | 1998-11-06 | Celulas huesped que expresan eritropoyetina humana recombinante y un metodo para producir un polipeptido de epo |
| ARP990100679 AR008363A1 (es) | 1999-02-23 | 1999-02-23 | Linea celular productora de eritropoyetina humana recombinante y la eritropoyetina humana recombinante producida por esta celula. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9905867A true BR9905867A (pt) | 2001-01-23 |
Family
ID=25590826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9905867-7A BR9905867A (pt) | 1998-11-06 | 1999-07-07 | Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1124984B1 (pt) |
| JP (2) | JP2002529100A (pt) |
| AT (1) | ATE420199T1 (pt) |
| AU (1) | AU1470400A (pt) |
| BR (1) | BR9905867A (pt) |
| CA (1) | CA2350335C (pt) |
| CO (1) | CO5241323A1 (pt) |
| DE (1) | DE69940267D1 (pt) |
| ES (1) | ES2321048T3 (pt) |
| WO (1) | WO2000028066A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9905868A (pt) | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Procedimento de cultivo massivo de células de mamìfero para a obtenção de eritropoetina humana, recombinante e a eritropoetina humana recombinante obtida com tal procedimento |
| BR9917606A (pt) * | 1998-11-06 | 2002-12-31 | Bio Sidus S A | Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento |
| US6777205B1 (en) | 1998-11-06 | 2004-08-17 | Sterrenbeld Biotechnologie North America, Inc. | Host cells expressing recombinant human erythropoietin |
| UA92913C2 (ru) * | 2005-06-20 | 2010-12-27 | Кадила Хелткере Лимитед | Экспрессионный вектор и способы продуцирования высоких уровней белков |
| EP2592147A1 (en) | 2007-10-12 | 2013-05-15 | F. Hoffmann-La Roche AG | Protein expression from multiple nucleic acids |
| CA2789696C (en) * | 2010-02-25 | 2017-11-07 | Dana-Farber Cancer Institute, Inc. | Braf mutations conferring resistance to braf inhibitors |
| CN103864913A (zh) | 2012-12-18 | 2014-06-18 | 联亚生技开发股份有限公司 | 重组蛋白 |
| PE20191360A1 (es) | 2017-03-10 | 2019-10-01 | Hoffmann La Roche | Metodo para producir anticuerpos multiespecificos |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5010002A (en) * | 1983-01-19 | 1991-04-23 | Genentech, Inc. | Human t-PA production using vectors coding DHFR protein |
| NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
| JPS62501010A (ja) * | 1984-12-04 | 1987-04-23 | ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド | エリトロポエチンの生産方法 |
| IL77081A (en) | 1984-12-04 | 1999-10-28 | Genetics Inst | Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin |
| US5641663A (en) * | 1985-11-06 | 1997-06-24 | Cangene Corporation | Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from steptomyces |
| JPS62171696A (ja) * | 1986-01-23 | 1987-07-28 | Sumitomo Chem Co Ltd | ヒトエリスロポエチンの製造方法 |
| JPH02485A (ja) * | 1987-08-03 | 1990-01-05 | Yuu Honshiyo | 新規なヒトインターロイキン4、該因子を発現させるための組換えベクター及びそのベクターにより形質転換された形質転換体 |
| IL95064A0 (en) * | 1990-07-12 | 1991-06-10 | Yeda Res & Dev | Molecular cloning of tnf binding protein |
| US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| WO1993000807A1 (en) * | 1991-07-03 | 1993-01-21 | Cryolife, Inc. | Method for stabilization of biomaterials |
| JPH05194253A (ja) * | 1992-01-16 | 1993-08-03 | Kirin Brewery Co Ltd | 水溶性ポリペプチドホルモンを含む徐放性微小粒子状製剤及びその製造法 |
| JP3790567B2 (ja) * | 1994-09-30 | 2006-06-28 | 武田薬品工業株式会社 | 徐放剤 |
| IL118201A (en) * | 1995-05-11 | 2004-12-15 | Roche Diagnostics Gmbh | Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof |
| DE19539574A1 (de) * | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
| JPH09238688A (ja) * | 1996-03-11 | 1997-09-16 | Takeda Chem Ind Ltd | ヒトmcp−1レセプタータンパク質の製造法および用途 |
| US6632648B1 (en) * | 1996-05-14 | 2003-10-14 | Elan Drug Delivery Limited | Methods of terminal sterilization of fibrinogen |
| US5851984A (en) * | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
| IL129565A0 (en) * | 1996-10-25 | 2000-02-29 | Searle & Co | Multi-functional chimeric hematopoietic receptor agonists |
| JPH10273447A (ja) * | 1997-01-29 | 1998-10-13 | Takeda Chem Ind Ltd | 徐放性マイクロスフィア、その製造法および用途 |
-
1999
- 1999-07-07 BR BR9905867-7A patent/BR9905867A/pt not_active Application Discontinuation
- 1999-11-05 CO CO99069968A patent/CO5241323A1/es active IP Right Grant
- 1999-11-08 ES ES99971863T patent/ES2321048T3/es not_active Expired - Lifetime
- 1999-11-08 WO PCT/US1999/026238 patent/WO2000028066A1/en not_active Ceased
- 1999-11-08 JP JP2000581232A patent/JP2002529100A/ja active Pending
- 1999-11-08 EP EP99971863A patent/EP1124984B1/en not_active Expired - Lifetime
- 1999-11-08 DE DE69940267T patent/DE69940267D1/de not_active Expired - Lifetime
- 1999-11-08 CA CA2350335A patent/CA2350335C/en not_active Expired - Fee Related
- 1999-11-08 AU AU14704/00A patent/AU1470400A/en not_active Abandoned
- 1999-11-08 AT AT99971863T patent/ATE420199T1/de not_active IP Right Cessation
-
2010
- 2010-03-16 JP JP2010059896A patent/JP2010213699A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1124984A4 (en) | 2005-05-04 |
| DE69940267D1 (de) | 2009-02-26 |
| CO5241323A1 (es) | 2003-01-31 |
| WO2000028066A1 (en) | 2000-05-18 |
| CA2350335A1 (en) | 2000-05-18 |
| JP2010213699A (ja) | 2010-09-30 |
| AU1470400A (en) | 2000-05-29 |
| JP2002529100A (ja) | 2002-09-10 |
| ES2321048T3 (es) | 2009-06-01 |
| EP1124984A1 (en) | 2001-08-22 |
| EP1124984B1 (en) | 2009-01-07 |
| CA2350335C (en) | 2013-02-26 |
| ATE420199T1 (de) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0574402B2 (en) | Expression of pace in host cells and methods of use thereof | |
| US6316253B1 (en) | Expression vectors, transfection systems, and method of use thereof | |
| NZ336200A (en) | Activating expression of an amplifying endogenous gene by homologous recombination | |
| WEISS et al. | Cis-acting elements are required for selenium regulation of glutathione peroxidase-1 mRNA levels | |
| Chen et al. | A new positive/negative selectable marker, puΔtk, for use in embryonic stem cells | |
| Ojaimi et al. | An algal nucleus-encoded subunit of mitochondrial ATP synthase rescues a defect in the analogous human mitochondrial-encoded subunit | |
| Larimer et al. | Intersubunit location of the active site of ribulose-bisphosphate carboxylase/oxygenase as determined by in vivo hybridization of site-directed mutants. | |
| US20220195416A1 (en) | Rna site-directed editing using artificially constructed rna editing enzymes and related uses | |
| ES2259422T3 (es) | Optimizacion de celulas para la activacion endogena del gen. | |
| EP0266190A3 (en) | Expression of protein c | |
| CA2203569A1 (en) | Nucleotide sequence encoding the enzyme i-scei and the uses thereof | |
| DE3880468D1 (de) | Rekombinante dns-expressionsvektoren. | |
| BR9905867A (pt) | Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula | |
| CA2035900A1 (fr) | Proteine a activite urate oxydase, gene recombinant codant pour celle-ci, vecteur d'expression, micro-organismes et cellules transformees | |
| FI862674A0 (fi) | Cdna.kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-vaextfaktoraktivitet. | |
| EP0293785A3 (en) | Cloning and expression of simian transforming growth factor-ss1 | |
| Bonin et al. | Photinus pyralis luciferase: vectors that contain a modified luc coding sequence allowing convenient transfer into other systems | |
| Matrajt et al. | Amino-terminal control of transgenic protein expression levels in Toxoplasma gondii | |
| DK638989D0 (da) | Fremgangsmaade til fremstilling af transformerende vaekstfaktor-beta1 samt derved anvendelige, eukaryotiske celler, cellelinier, polypeptider og nucleotidsekvenser | |
| CA2328506A1 (en) | Modifying the expression of the fsh beta gene by homologous recombination | |
| US6762038B1 (en) | Mutant cell lines and methods for producing enhanced levels of recombinant proteins | |
| AR008363A1 (es) | Linea celular productora de eritropoyetina humana recombinante y la eritropoyetina humana recombinante producida por esta celula. | |
| JP2007228814A (ja) | 外来タンパク質の発現用遺伝子カセットおよび外来タンパク質の製造方法 | |
| Gunaratne et al. | An evolutionarily conserved palindrome in the Drosophila Gld promoter directs tissue-specific expression. | |
| ES2255177T5 (es) | Fabricación de proteínas mutadas humanas en células humanas por medio de la recombinación homóloga. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 37 INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE A MATERIA PLEITEADA NAO E CONSIDERADA PATENTEAVEL, DIANTE DO ART. 18 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |